Henry Schein Inc (HSIC) is a publicly traded Healthcare sector company. As of May 20, 2026, HSIC trades at $73.23 with a market cap of $8.28B and a P/E ratio of 23.93. HSIC moved +0.43% today. Year to date, HSIC is -6.76%; over the trailing twelve months it is +0.14%. Its 52-week range spans $60.56 to $89.29. Analyst consensus is buy with an average price target of $87.43. Rallies surfaces HSIC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HSIC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HSIC recently traded at $73.23. Market cap is $8.28B. P/E ratio is 23.93. Revenue is $12.67B.
| Metric | Value |
|---|---|
| Price | $73.23 |
| Market Cap | $8.28B |
| P/E Ratio | 23.93 |
| EPS | $3.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $89.29 |
| 52-Week Low | $60.56 |
| Volume | 1.07M |
| Avg Volume | 0 |
| Revenue (TTM) | $12.67B |
| Net Income | $398.00M |
| Gross Margin | 31.69% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $12.67B | $398.00M | $3.07 |
| 2023 | $12.34B | $436.00M | $3.18 |
| 2022 | $12.65B | $566.00M | $3.95 |
| 2021 | $12.40B | $660.53M | $4.51 |
16 analysts cover HSIC: 0 strong buy, 8 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $87.43.